Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Biotin-responsive basal ganglia disease: a novel entity.Brain. 1998; 121: 1267-1279
- Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings.Neurology. 2013; 80: 261-267
- SLC19A3 gene defects sorting the phenotype and acronyms: review.Neuropediatrics. 2018; 49: 083-092
- Report of the largest Chinese cohort with SLC19A3 gene defect and literature review.Front Genet. 2021; 12: 683255
- Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening.Ann Clin Transl Neurol. 2019; 6: 2097-2103
- Early infantile Leigh-like SLC19A3 gene defects have a poor prognosis: report and review.J Cent Nerv Syst Dis. 2017; 9 (1179573517737521)
- Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy.N Eng J Med. 2009; 360: 1792-1794
- Biotin responsive basal ganglia disease: neuroimaging features before and after treatment.Am J Neuroradiol. 2014; 35: 1990-1995
- Unusual case of biotin-thiamine responsive encephalopathy without basal ganglia involvement.Pediatr Radiol. 2021; 51: 485-488
- Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine responsive basal ganglia disease?.Eur J Paediatr Neurol. 2018; 22: 1139-1149
- Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.Folia Neuropathol. 2017; 55: 146-153
- Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease.Brain Pathol. 2014; 24: 270-279